Alkem Laboratories Annual Report 2015-16

Alkem Laboratories' 2015-16 annual report highlights the company's dual growth strategy: consolidating its position in India with a portfolio of 700 brands across multiple therapies, while expanding into high-value US and emerging markets. The company delivered net revenue of ₹49.9 billion with strong manufacturing, R&D capabilities, and an extensive sales network.